KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $75.2 million.

  • Vir Biotechnology's Total Current Liabilities fell 3579.6% to $75.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.2 million, marking a year-over-year decrease of 3579.6%. This contributed to the annual value of $119.7 million for FY2024, which is 3178.04% down from last year.
  • As of Q3 2025, Vir Biotechnology's Total Current Liabilities stood at $75.2 million, which was down 3579.6% from $105.0 million recorded in Q2 2025.
  • Vir Biotechnology's 5-year Total Current Liabilities high stood at $702.4 million for Q1 2022, and its period low was $75.2 million during Q3 2025.
  • Moreover, its 5-year median value for Total Current Liabilities was $175.4 million (2023), whereas its average is $256.7 million.
  • Per our database at Business Quant, Vir Biotechnology's Total Current Liabilities skyrocketed by 54029.19% in 2021 and then crashed by 8061.6% in 2024.
  • Over the past 5 years, Vir Biotechnology's Total Current Liabilities (Quarter) stood at $341.2 million in 2021, then soared by 49.76% to $511.0 million in 2022, then plummeted by 65.68% to $175.4 million in 2023, then tumbled by 31.78% to $119.7 million in 2024, then plummeted by 37.14% to $75.2 million in 2025.
  • Its Total Current Liabilities stands at $75.2 million for Q3 2025, versus $105.0 million for Q2 2025 and $137.3 million for Q1 2025.